Effect of syngeneic tumor tRNA on MOPC 315 myeloma in BALB-cCR mouse.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000951:Antigens, Neoplasm / Q000494:pharmacology; D002470:Cell Survival; D003601:Cytotoxicity Tests, Immunologic; D006644:Histiocytes / Q000276:immunology; D007109:Immunity / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology; D008722:Methods; D051379:Mice; D008815:Mice, Inbred Strains; D009000:Monocytes / Q000276:immunology; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010586:Phagocytes / Q000276:immunology; D012334:RNA, Neoplasm / Q000627:therapeutic use*; D012343:RNA, Transfer / Q000627:therapeutic use*
D000951:Antigens, Neoplasm; D012334:RNA, Neoplasm; D012343:RNA, Transfer